Aytu BioScience, Inc. (AYTU) Reaches $0.30 Yearly Low; Botty Investors Has Upped By $486,696 Its Mlp Westn Gas Partners LP (WES) Holding

June 10, 2018 - By Henry Gaston

Western Gas Partners, LP (NYSE:WES) Logo

Botty Investors Llc increased Mlp Westn Gas Partners Lp (WES) stake by 615.73% reported in 2018Q1 SEC filing. Botty Investors Llc acquired 11,588 shares as Mlp Westn Gas Partners Lp (WES)’s stock rose 5.40%. The Botty Investors Llc holds 13,470 shares with $575,000 value, up from 1,882 last quarter. Mlp Westn Gas Partners Lp now has $8.00B valuation. The stock decreased 1.53% or $0.8 during the last trading session, reaching $51.55. About 417,917 shares traded. Western Gas Partners, LP (NYSE:WES) has declined 9.71% since June 10, 2017 and is downtrending. It has underperformed by 22.28% the S&P500. Some Historical WES News: ; 17/04/2018 – WESTERN GAS REPORTS 1Q DISTRIBUTION OF $0.9350/UNIT; 01/05/2018 – WESTERN GAS PARTNERS 1Q ADJ EBITDA $272.1M, EST. $274.4M; 03/05/2018 – Enterprise, Enbridge, Western Gas Partners and DCP Midstream Conduct Open Season for Texas Express Expansion; 01/05/2018 – Western Gas Partners 1Q EPS 38c; 13/05/2018 – Western Gas Names New Chief Operating Officer; 15/03/2018 Financial Review: #BREAKING: @Wesfarmers to spin off @Coles into separate ASX company.$WES #ausbiz; 19/04/2018 – DJ Western Gas Partners LP, Inst Holders, 1Q 2018 (WES); 03/05/2018 – WESTERN GAS PARTNERS LP WES.N : CITIGROUP RAISES TARGET PRICE TO $53 FROM $46; 13/05/2018 – WESTERN GAS NAMES GENNIFER F. KELLY AS NEW COO; 03/05/2018 – Enterprise, Western Gas Partners, and DCP Midstream Seek to Expand the Front Range Pipeline

The stock of Aytu BioScience, Inc. (NASDAQ:AYTU) hit a new 52-week low and has $0.27 target or 8.00% below today’s $0.30 share price. The 5 months bearish chart indicates high risk for the $10.60M company. The 1-year low was reported on Jun, 10 by Barchart.com. If the $0.27 price target is reached, the company will be worth $847,840 less. The stock decreased 2.67% or $0.0081 during the last trading session, reaching $0.2953. About 998,673 shares traded. Aytu BioScience, Inc. (NASDAQ:AYTU) has declined 97.39% since June 10, 2017 and is downtrending. It has underperformed by 109.96% the S&P500.

Investors sentiment increased to 1.21 in Q1 2018. Its up 0.46, from 0.75 in 2017Q4. It increased, as 20 investors sold WES shares while 47 reduced holdings. 23 funds opened positions while 58 raised stakes. 89.37 million shares or 0.82% less from 90.11 million shares in 2017Q4 were reported. Castleark Mgmt Limited Liability Corp holds 0.12% or 90,361 shares. Linscomb And Williams Incorporated accumulated 9,855 shares. Washington-based Evergreen Mgmt Lc has invested 0.96% in Western Gas Partners, LP (NYSE:WES). Hilton Mngmt Lc reported 0.23% in Western Gas Partners, LP (NYSE:WES). Salient Advsrs Limited has invested 0.11% of its portfolio in Western Gas Partners, LP (NYSE:WES). Ftb Advsrs has 1,180 shares for 0% of their portfolio. Rafferty Asset Mgmt Ltd reported 56,368 shares stake. M&T Comml Bank accumulated 115,206 shares. Ancora Advsrs Ltd owns 7,627 shares. Fifth Third Retail Bank holds 0% in Western Gas Partners, LP (NYSE:WES) or 1,200 shares. Parallax Volatility Advisers Limited Partnership reported 14 shares or 0% of all its holdings. Williams Jones & Associate Limited Liability Company invested in 0.05% or 46,382 shares. Keybank National Association Oh has 9,015 shares for 0% of their portfolio. Security Trust Company invested 0.07% of its portfolio in Western Gas Partners, LP (NYSE:WES). Whalerock Point Prtnrs Limited Liability accumulated 5,500 shares.

Among 19 analysts covering Western Gas Partners (NYSE:WES), 11 have Buy rating, 0 Sell and 8 Hold. Therefore 58% are positive. Western Gas Partners had 54 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was maintained by on Monday, October 10 with “Overweight”. UBS maintained the stock with “Buy” rating in Friday, March 2 report. The company was maintained on Sunday, August 20 by RBC Capital Markets. RBC Capital Markets maintained the shares of WES in report on Tuesday, January 16 with “Buy” rating. Credit Suisse downgraded Western Gas Partners, LP (NYSE:WES) rating on Thursday, March 17. Credit Suisse has “Neutral” rating and $53 target. The rating was maintained by Barclays Capital with “Equal-Weight” on Wednesday, March 7. The company was initiated on Thursday, January 14 by CapitalOne. The firm earned “Buy” rating on Thursday, October 26 by Stifel Nicolaus. The stock of Western Gas Partners, LP (NYSE:WES) has “Overweight” rating given on Wednesday, March 14 by JP Morgan. On Tuesday, January 12 the stock rating was downgraded by Bank of America to “Neutral”.

Another recent and important Western Gas Partners, LP (NYSE:WES) news was published by Prnewswire.com which published an article titled: “Western Gas To Present At Upcoming Bank Of America Merrill Lynch Conference” on May 03, 2018.

Another recent and important Aytu BioScience, Inc. (NASDAQ:AYTU) news was published by Benzinga.com which published an article titled: “Benzinga’s Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway” on May 15, 2018.

Aytu BioScience, Inc., a specialty healthcare company, focuses on developing and commercializing novel products in the field of urology in the United States. The company has market cap of $10.60 million. The firm markets Natesto for the treatment of hypogonadism in men; and ProstaScint for use in newly diagnosed high-risk prostate cancer patients and patients with recurrent prostate cancer. It currently has negative earnings. It is also involved in commercializing of the RedoxSYS System for research use in various applications.

Western Gas Partners, LP (NYSE:WES) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: